MedTrace Logo

Periocular Rejuvenation by Topical Hyaluronic Acid Nano Particles

NCT05742399 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-01-31

No results posted yet for this study

Summary

In this study, The investigators aims to evaluate the efficacy and safety of topical hyaluronic acid nanoparticles as a novel nanodermatological tool in periocular rejuvenation as a replacement approach of invasive dermal filler injections.

Conditions

  • Tear Trough Eyelid Deformity
  • Dark Eyelids
  • Wrinkle

Interventions

DRUG

Hyaluronic acid NanoGel

Hyaluronic acid nanoparticles (2%)

DRUG

Placebo gel

conventional gel having the same color, form and packaging

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Yosra S.R Elnaggar, MD · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-21
Primary Completion
2023-09-15
Completion
2024-01-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05742399 on ClinicalTrials.gov